{"id":"W2906444991","doi":"10.1016/j.jval.2018.09.2438","title":"PRS44 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS UMEC/VI IN PATIENTS WITH COPD: COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Fluticasone propionate; COPD; Cost effectiveness; Quality-adjusted life year; Inhaler; Exacerbation; Internal medicine; Asthma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007571897,0.0007157312,0.00125356,0.0005889466,0.0006120431,0.001715692,0.001014142,0.001114437,0.007094765],"category_scores_gemma":[0.01450673,0.0002779843,0.003542014,0.001250732,0.0005859332,0.0009093483,0.001063321,0.001641526,0.0002423844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0257399,"about_ca_system_score_gemma":0.03604613,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8512408,"about_ca_topic_score_gemma":0.838012,"domain_scores_codex":[0.9945504,0.003916725,0.0002065992,0.0002606076,0.0004939265,0.0005717235],"domain_scores_gemma":[0.9939361,0.003042353,0.0008214719,0.0001823618,0.0009924569,0.001025324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2153594,0.01090413,0.173668,0.004822375,0.01347965,0.0003161036,0.0005837759,0.1166686,0.001360977,0.005684113,0.0264315,0.4307215],"study_design_scores_gemma":[0.1072332,0.04439323,0.6483225,0.002903871,0.01433281,0.0001609754,0.001328613,0.1638532,0.001139873,0.002362099,0.01366189,0.0003077809],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9561471,0.00855772,0.001475983,0.00691056,0.0002150682,0.002403266,0.012266,0.00009370141,0.01193064],"genre_scores_gemma":[0.9919611,0.001369002,0.001730686,0.0006032409,0.00004135905,0.0004138071,0.002547151,0.000009257318,0.001324352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1487592,"threshold_uncertainty_score":0.2992705,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3046077889044924,"score_gpt":0.4269383488251285,"score_spread":0.1223305599206361,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}